fusion
blymphocyt
immun
anim
myeloma
cell
result
format
hybrid
cell
known
hybridoma
grow
continu
secret
antibodi
cell
may
select
clone
stabl
secret
antibodi
defin
specif
continu
cultur
clone
cell
line
allow
prepar
monoclon
antibodi
larg
quantiti
monoclon
antibodi
produc
way
avail
varieti
therapeut
purpos
antitumour
therapi
immunomodul
passiv
immun
well
viva
diagnosi
prepar
procedur
biolog
requir
set
intend
appli
monoclon
antibodi
obtain
hybridoma
murin
origin
therapeut
viva
diagnost
use
human
monoclon
antibodi
intend
use
purif
product
shown
pure
free
adventiti
agent
method
describ
document
monoclon
antibodi
use
diagnost
purpos
vitro
concern
paper
import
consider
clinic
use
monoclon
antibodi
murin
origin
possibl
unintent
immunolog
crossreact
antibodi
human
tissu
antigen
desir
possibl
presenc
virus
andor
potenti
oncogen
macromolecul
gener
problem
therapeut
use
murin
monoclon
antibodi
man
may
induct
antibodi
recipi
murin
immunoglobulin
protein
present
product
may
result
advers
reaction
limit
durat
effect
antibodi
therapi
may
prudent
minim
murin
protein
load
administ
patient
use
parent
myeloma
cell
synthes
immunoglobulin
chain
flexibl
approach
control
monoclon
antibodi
adopt
requir
modifi
light
experi
gain
product
clinic
use
detail
implement
requir
individu
product
gener
reflect
circumst
product
use
exampl
clinic
indic
paper
propos
note
manufactur
monoclon
antibodi
intend
help
assembl
inform
need
support
applic
market
author
within
eec
establish
appropri
control
test
sever
requir
relat
establish
biolog
product
manufactur
eg
revis
requir
biolog
substanc
tr
requir
manufactur
establish
control
laboratori
appli
manufactur
monoclon
antibodi
attent
drawn
follow
point
product
area
decontamin
use
manufactur
monoclon
antibodi
product
monoclon
antibodi
perform
staff
whose
state
health
compromis
qualiti
product
otherwis
involv
work
could
result
infecti
agent
transmit
monoclon
antibodi
product
person
directli
concern
product
process
offici
repres
nation
control
author
permit
enter
product
area
particular
emphasi
given
recommend
contain
part
section
revis
requir
biolog
substanc
tr
page
regard
train
experi
person
charg
product
test
assign
variou
area
respons
manufactur
establish
mani
gener
requir
qualiti
control
biolog
product
potenc
abnorm
toxic
test
absenc
advers
immunolog
reaction
freedom
inappropri
contamin
stabil
freedom
antibiot
appli
monoclon
antibodi
undesir
use
product
agent
known
provok
sensit
reaction
certain
individu
exampl
penicillin
lactam
antibiot
addit
follow
point
set
consid
appli
monoclon
antibodi
obtain
hybridoma
murinemurin
origin
monoclon
antibodi
produc
hybridoma
parentag
technolog
may
requir
differ
control
measur
whenev
possibl
murin
tissu
anim
use
sourc
materi
shown
free
virus
indic
appendix
sourc
name
characterist
parent
myeloma
cell
line
given
shown
cell
line
pure
cultur
either
mous
rat
myeloma
cell
contain
cell
origin
detail
immunoglobulin
chain
synthes
secret
cell
includ
myeloma
cell
line
use
fusion
prefer
select
one
synthes
immunoglobulin
chain
cryopreserv
sampl
myeloma
cell
retain
case
retrospect
investig
becom
necessari
sourc
immun
parent
cell
includ
inform
speci
strain
immun
procedur
use
prepar
donor
anim
provid
sourc
immunogen
also
given
immunogen
deriv
human
sourc
inform
health
donor
provid
relev
clinic
data
donor
must
report
complet
descript
product
hybridoma
cell
line
provid
includ
detail
cell
fusion
clone
reclon
procedur
suffici
data
given
allow
assess
effici
clone
procedur
feeder
cell
use
deriv
anim
cell
seed
stock
shown
free
virus
test
describ
appendix
characterist
hybridoma
cell
line
detail
includ
specif
class
appropri
subclass
immunoglobulin
secret
togeth
distinguish
featur
isoenzymeimmunochem
marker
record
whether
hybridoma
secret
parent
myeloma
immunoglobulin
chain
shown
cell
line
stabl
respect
antibodi
secret
beyond
passag
level
use
routin
product
appropri
precaut
taken
avoid
crosscontamin
cell
immunolog
properti
antibodi
describ
detail
includ
antigen
specif
complement
bind
unintent
reactiv
cytotox
human
tissu
distinct
intend
target
antigen
appendix
ii
contain
list
tissu
among
test
essenti
product
base
clearli
delin
seed
lot
system
involv
master
cell
bank
manufactur
work
cell
bank
describ
detail
number
vial
cell
bank
avail
inform
storag
provid
order
establish
seed
lot
cell
origin
hybridoma
line
propag
vitro
wherev
possibl
confirm
either
mous
rat
origin
appropri
cell
line
handl
simultan
laboratori
person
establish
seed
lot
inform
provid
stabil
antibodi
secret
cell
cell
bank
storag
recoveri
sampl
seed
must
retain
least
expiri
date
result
final
lot
evid
cell
seed
lot
free
microbi
contamin
viral
bacteri
mycot
mycoplasm
provid
appropri
test
demonstr
absenc
viru
contamin
describ
b
c
appendix
perform
examin
cell
line
transmiss
scan
electron
microscopi
may
provid
valuabl
inform
viral
contamin
except
circumst
seed
lot
contain
virus
endogen
murin
retrovirus
consid
product
circumst
cell
line
contamin
virus
list
appendix
tabl
group
known
caus
diseas
man
polyoma
viru
use
product
propos
purif
procedur
use
product
monoclon
antibodi
shown
capabl
remov
andor
inactiv
retrovirus
present
virus
clearli
state
whether
cell
cultur
supernat
ascit
fluid
use
sourc
antibodi
vitro
product
monoclon
antibodi
finit
passag
level
offer
prospect
higher
degre
control
standard
viva
product
prefer
method
ideal
one
cell
line
cultiv
time
product
area
howev
cell
line
cultiv
parallel
record
must
kept
cell
line
handl
evid
present
absenc
crosscontamin
product
batch
normal
origin
fresh
ampoul
seed
descript
cell
cultur
techniqu
employ
fullscal
product
cycl
provid
togeth
criteria
cell
supernat
must
meet
accept
process
eg
titr
monoclon
antibodi
maximum
permit
number
cell
popul
doubl
start
afresh
sampl
seed
lot
eg
manufactur
work
cell
bank
defin
base
inform
concern
stabil
hybridoma
cell
line
prolong
cultiv
eg
yield
monoclon
antibodi
distribut
characterist
cell
marker
particular
attent
given
degre
natur
microbi
contamin
cultur
vessel
cultur
anim
serumderiv
addit
use
shown
free
adventiti
agent
eg
calf
serum
free
bovin
diarrhoea
viru
potenti
contamin
bulk
cultur
fluid
shown
free
mycoplasm
mycot
bacteri
contamin
test
presenc
virus
use
gener
test
involv
inocul
suitabl
cell
substrat
describ
procedur
given
appendix
test
b
extent
natur
test
agre
casebycas
basi
nation
control
author
control
standard
continu
cultur
product
pose
consider
problem
howev
demonstr
method
clearli
advantag
aspect
rigor
control
may
consid
product
monoclon
antibodi
case
particular
attent
given
stabil
hybridoma
process
yield
integr
monoclon
antibodi
obtain
clear
definit
batch
product
given
shown
consecut
batch
yield
consist
product
regular
test
microbi
contamin
perform
criteria
reject
harvest
prematur
termin
cultur
defin
period
continu
cultiv
specifi
base
inform
concern
stabil
system
consist
product
beyond
limit
case
longterm
continu
cultiv
hybridoma
monoclon
antibodi
complet
reevalu
set
section
interv
base
inform
concern
stabil
system
charact
product
product
batch
origin
fresh
ampoul
seed
eg
manufactur
work
cell
bank
maximum
permiss
number
serial
passag
vivo
normal
product
defin
restrict
justif
limit
includ
inform
concern
yield
monoclon
antibodi
stabil
hybridoma
characterist
vivo
passag
beyond
use
product
indefinit
passag
anim
accept
b
strain
origin
anim
use
product
specifi
togeth
genotyp
age
close
specif
pathogenfre
spf
coloni
routin
monitor
virus
list
appendix
tabl
longterm
record
mous
breed
coloni
respect
freedom
viral
contamin
consid
relat
reliabl
mainten
coloni
evid
also
present
anim
maintain
spf
condit
time
transfer
use
number
anim
procedur
use
prepar
bulk
ascit
harvest
given
detail
full
detail
provid
substanc
use
pretreat
mice
rat
facilit
growth
hybridoma
data
concern
titr
antibodi
storag
condit
bulk
ascit
fluid
provid
eg
temperatur
durat
detail
proteolyt
enzym
inhibitor
ad
particular
attent
paid
degre
natur
microbi
contamin
bacteri
mycot
mycoplasm
bulk
ascit
fluid
test
procedur
capabl
detect
murin
virus
list
appendix
tabl
perform
indic
appendix
b
least
first
five
bulk
harvest
product
howev
may
expect
gener
test
method
virus
may
suffici
experi
product
gain
consequ
first
five
product
run
gener
test
virus
limit
describ
appendix
test
b
may
consid
adequ
infecti
agent
identifi
test
virus
appendix
ii
group
tabl
neg
sourc
mice
chang
differ
coloni
supplier
test
describ
appendix
perform
least
first
five
bulk
harvest
reestablish
consist
freedom
contamin
agent
purif
antibodi
procedur
use
purifi
monoclon
antibodi
cultur
supernat
fluid
ascit
fluid
describ
detail
import
ensur
purif
procedur
impair
relev
immunobiolog
featur
immunoglobulin
consider
given
incorpor
procedur
inactiv
potenti
viral
contamin
method
compromis
biolog
activ
product
capac
purif
procedur
remov
contamin
includ
unwant
immunoglobulin
dna
virus
irrit
pristan
use
gener
ascit
demonstr
reproduc
purif
process
success
product
run
pilot
scale
studi
use
repres
collect
virus
possess
rang
biophys
structur
featur
includ
retrovirus
radioact
label
compound
eg
dna
crude
prepar
spike
perform
reduct
factor
contamin
stage
purif
process
overal
defin
report
use
necessari
concentr
dna
virus
excess
expect
normal
product
inactiv
process
use
shown
effect
compromis
biolog
activ
product
precis
criteria
puriti
monoclon
antibodi
product
especi
respect
protein
dna
compon
provid
analyt
test
includ
exampl
column
chromatographi
includ
hplc
isoelectr
focus
sd
page
reduc
nonreduc
condit
dna
assay
method
specif
limit
set
contamin
includ
dna
protein
may
deriv
parent
cell
host
anim
tissu
cultur
medium
manufactur
procedur
dna
content
particularli
dna
hybridoma
origin
assay
sensit
reliabl
assay
method
characterist
describ
detail
current
dna
hybrid
techniqu
sensit
method
specif
limit
given
specif
activ
ie
antibodi
activ
per
unit
weight
protein
establish
standard
appropri
assay
refer
batch
monoclon
antibodi
prefer
produc
vitro
purifi
thoroughli
possibl
prepar
final
bulk
product
shown
free
bacteri
fungal
mycoplasm
contamin
test
virus
accord
appendix
tabl
evid
present
show
viral
contamin
known
present
bulk
harvest
elimin
inactiv
materi
earli
batch
clinic
evalu
retain
work
refer
prepar
puriti
potenc
compar
futur
batch
addit
highli
purifi
monoclon
antibodi
prepar
made
vitro
cultur
method
establish
see
permit
determin
specif
activ
final
contain
shown
compli
exist
gener
eec
requir
exampl
steril
pyrogen
abnorm
toxic
etc
particular
attent
given
assess
degre
aggreg
molecular
fragment
immunoglobulin
possibl
step
taken
prevent
aggreg
least
immunoglobulin
present
form
molecular
monom
dimer
departur
limit
justifi
evid
provid
consist
product
exampl
least
five
consecut
fullscal
product
batch
includ
inform
bulk
harvest
final
dosag
form
well
inprocess
control
test
purpos
may
desir
modifi
monoclon
antibodi
eg
conjug
toxin
radiolabel
attach
specif
drug
target
product
addit
specif
control
procedur
requir
dealt
best
casebycas
basi
addit
detail
descript
prepar
purif
gener
requir
product
might
includ
inform
concern
halflif
monoclon
antibodi
drug
toxin
also
conjug
inject
recipi
inform
crossreact
conjug
well
antibodi
would
requir
would
data
concern
toxic
stabil
conjug
modif
antibodi
could
potenti
chang
antigen
specif
examin
detail
particular
refer
presenc
unintent
reactiv
modifi
antibodi
human
tissu
appendix
ii
applic
subfrag
antibodi
eg
fab
f
ab
may
advantag
fragment
prefer
clinic
use
molecular
antigen
properti
defin
f
ab
z
fab
use
specifi
limit
impur
exampl
fragment
desir
intact
immunoglobulin
defin
compli
definit
exist
immunoglobulin
prepar
inform
describ
section
provid
upper
limit
set
residu
level
product
enzym
use
process
eg
pepsin
papain
gener
classic
toxicolog
studi
anim
may
limit
relev
studi
monoclon
antibodi
howev
limit
safeti
test
usual
requir
product
thu
finish
product
complet
manufactur
process
obtain
bulk
harvesr
supernat
ascit
fluid
maintain
singl
contain
use
prepar
final
dosag
form
gener
final
batch
clearli
defin
unambigu
record
manufactur
finish
product
formul
put
seal
contain
hold
liquid
freezedri
product
final
dosag
form
contain
fill
lot
process
togeth
uniform
content
biolog
potenc
